NB
Narendra Babulal Pakhawala
About Narendra Babulal Pakhawala
Data last updated:
Narendra Babulal Pakhawala is a Director at Aies Pharma Chem Private Limited (since 2018) and Director at Nayasa Innovation Private Limited (since 2022). The companies operate in Pharma and Business Outsourcing. The largest current company by reported revenue is Aies Pharma Chem Private Limited at ₹8.95 Cr (FY 2025). Earlier, Narendra Babulal Pakhawala was a Designated Partner at Roman Buildcon Llp (2024–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 05 Dec 2018 | 2018 | ₹8.95 Cr (FY 2025) | Active | |
| Director | 28 Mar 2022 | 2011 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 07 Mar 2024 | 2024 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Narendra Babulal Pakhawala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jitendrakumar Shankarlal Modi | 08177888 | Aies Pharma Chem Private Limited | Director |
| Mrugesh Jitendrakumar Modi | 08177889 | Aies Pharma Chem Private Limited | Director |
| Nita Viren Doshi | 02845237 | Nayasa Innovation Private Limited | Director |
| Rohit Babulal Pakhawala | 10539832 | Nayasa Innovation Private Limited | Director |
| Viren Shamaldas Doshi | 02845277 | Nayasa Innovation Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narendra Babulal Pakhawala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narendra Babulal Pakhawala
Narendra Babulal Pakhawala currently holds 2 directorships: Aies Pharma Chem Private Limited (Director, since 05 Dec 2018, revenue βΉ8.95 Cr (FY 2025)); Nayasa Innovation Private Limited (Director, since 28 Mar 2022).
Narendra Babulal Pakhawala was first appointed on 05 Dec 2018 as Director at Aies Pharma Chem Private Limited. The most recent appointment on record is 07 Mar 2024 at Roman Buildcon Llp.
Narendra Babulal Pakhawala held 1 earlier board appointment: Roman Buildcon Llp (Designated Partner, 07 Mar 2024 to 14 Jun 2025).
The current boards of Narendra Babulal Pakhawala's companies include Jitendrakumar Shankarlal Modi (Aies Pharma Chem Private Limited), Mrugesh Jitendrakumar Modi (Aies Pharma Chem Private Limited), Nita Viren Doshi (Nayasa Innovation Private Limited), Rohit Babulal Pakhawala (Nayasa Innovation Private Limited), Viren Shamaldas Doshi (Nayasa Innovation Private Limited).